NICO Corporation is progressing minimally invasive corridor neurosurgery by creating instruments that allow for safe tumor and cyst removal through smaller openings. This provides neurosurgeons opportunities for less brain retraction, shorter total resection time, and precise control
to achieve a more effective gross total resection. NICO’s products offer the potential for less surgical trauma for patients, shorter hospital stays, better clinical outcomes, and improved clinical experiences.
The NICO Myriad product portfolio offers a diverse product line designed to address the
2+ million patients worldwide who are diagnosed with intracranial brain abnormalities every year.
Its proprietary tissue resection and capture technology can delive r biologically viable tissue for use
by pathology in disease diagnosis and in oncology for use in the advancement and creation of more effective and compassionate personalized patient treatment regimens.
This is why neurosurgeons say the NICO Myriad is “the most significant advancement in neurosurgery in the past decade” and a “revolutionary tool” that “really does all that it claims
[to do] to advance our ability to remove tumors”. It is the goal of NICO to ultimately improve the
quality of life for patients through proven innovation and compassionate clinical care.